Breast Cancer Liquid Biopsy Market Size, Share & Trends Report

Breast Cancer Liquid Biopsy Market Size, Share & Trends Analysis Report By Circulating Biomarkers (Circulating Tumor Cells, Circulating Cell-free DNA, Extracellular Vesicles), By Application, By Region, And Segment Forecasts, 2022 - 2030

Report ID: GVR-4-68039-991-9
Number of Pages: 130
Format: Electronic (PDF)

Historical Range: 2018 - 2020
Industry: Healthcare

Market Segmentation

Breast Cancer Liquid Biopsy Circulating Biomarkers Outlook (Revenue, USD Million, 2018 - 2030)
- Circulating Tumor Cells (CTCs)
- Circulating Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
Breast Cancer Liquid Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
Breast Cancer Liquid Biopsy Regional Outlook (Revenue, USD Million, 2018- 2030)
- North America
  - North America Cardiac Biomarkers Market, By Circulating Biomarkers
    - Circulating Tumor Cells (CTCs)
    - Circulating Cell-free DNA (cfDNA)
    - Extracellular Vesicles (EVs)
    - Other Circulating Biomarkers
  - North America Cardiac Biomarkers Market, By Application,
    - Early Detection/Screening
    - Diagnosis
    - Treatment Selection
    - Monitoring
  - U.S.
    - U.S. Cardiac Biomarkers Market, By Circulating Biomarkers
      - Circulating Tumor Cells (CTCs)
      - Circulating Cell-free DNA (cfDNA)
      - Extracellular Vesicles (EVs)
      - Other Circulating Biomarkers
    - U.S. Cardiac Biomarkers Market, By Application,
      - Early Detection/Screening
      - Diagnosis
      - Treatment Selection
      - Monitoring
  - Canada
    - Canada Cardiac Biomarkers Market, By Circulating Biomarkers
      - Circulating Tumor Cells (CTCs)
      - Circulating Cell-free DNA (cfDNA)
      - Extracellular Vesicles (EVs)
      - Other Circulating Biomarkers
    - Canada Cardiac Biomarkers Market, By Application,
      - Early Detection/Screening
      - Diagnosis
      - Treatment Selection
      - Monitoring
- Europe
  - Europe Cardiac Biomarkers Market, By Circulating Biomarkers
    - Circulating Tumor Cells (CTCs)
    - Circulating Cell-free DNA (cfDNA)
    - Extracellular Vesicles (EVs)
    - Other Circulating Biomarkers
  - Europe Cardiac Biomarkers Market, By Application,
    - Early Detection/Screening
    - Diagnosis
    - Treatment Selection
    - Monitoring
  - U.K.
    - U.K. Cardiac Biomarkers Market, By Circulating Biomarkers
      - Circulating Tumor Cells (CTCs)
      - Circulating Cell-free DNA (cfDNA)
      - Extracellular Vesicles (EVs)
      - Other Circulating Biomarkers
    - U.K. Cardiac Biomarkers Market, By Application,
      - Early Detection/Screening
      - Diagnosis
      - Treatment Selection
      - Monitoring
    - Germany
      - Germany Cardiac Biomarkers Market, By Circulating Biomarkers
        
        Circulating Tumor Cells (CTCs)
        
        Circulating Cell-free DNA (cfDNA)
        
        Extracellular Vesicles (EVs)
        
        Other Circulating Biomarkers
      - Germany Cardiac Biomarkers Market, By Application,
        
        Early Detection/Screening
        
        Diagnosis
        
        Treatment Selection
        
        Monitoring
    - France
      - France Cardiac Biomarkers Market, By Circulating Biomarkers
        
        Circulating Tumor Cells (CTCs)
        
        Circulating Cell-free DNA (cfDNA)
        
        Extracellular Vesicles (EVs)
        
        Other Circulating Biomarkers
      - France Cardiac Biomarkers Market, By Application,
        
        Early Detection/Screening
        
        Diagnosis
        
        Treatment Selection
        
        Monitoring
    - Italy
      - Italy Cardiac Biomarkers Market, By Circulating Biomarkers
        
        Circulating Tumor Cells (CTCs)
        
        Circulating Cell-free DNA (cfDNA)
        
        Extracellular Vesicles (EVs)
        
        Other Circulating Biomarkers
      - Italy Cardiac Biomarkers Market, By Application,
        
        Early Detection/Screening
        
        Diagnosis
        
        Treatment Selection
        
        Monitoring
    - Spain
      - Spain Cardiac Biomarkers Market, By Circulating Biomarkers
        
        Circulating Tumor Cells (CTCs)
        
        Circulating Cell-free DNA (cfDNA)
        
        Extracellular Vesicles (EVs)
        
        Other Circulating Biomarkers
      - Spain Cardiac Biomarkers Market, By Application,
        
        Early Detection/Screening
        
        Diagnosis
        
        Treatment Selection
        
        Monitoring
- Asia Pacific
  - Asia Pacific Cardiac Biomarkers Market, By Circulating Biomarkers
    - Circulating Tumor Cells (CTCs)
    - Circulating Cell-free DNA (cfDNA)
    - Extracellular Vesicles (EVs)
    - Other Circulating Biomarkers
  - Asia Pacific Cardiac Biomarkers Market, By Application,
    - Early Detection/Screening
    - Diagnosis
    - Treatment Selection
    - Monitoring
  - Japan
    - Japan Cardiac Biomarkers Market, By Circulating Biomarkers
      - Circulating Tumor Cells (CTCs)
      - Circulating Cell-free DNA (cfDNA)
      - Extracellular Vesicles (EVs)
      - Other Circulating Biomarkers
    - Japan Cardiac Biomarkers Market, By Application,
      - Early Detection/Screening
      - Diagnosis
      - Treatment Selection
      - Monitoring
  - China
    - China Cardiac Biomarkers Market, By Circulating Biomarkers
      - Circulating Tumor Cells (CTCs)
      - Circulating Cell-free DNA (cfDNA)
      - Extracellular Vesicles (EVs)
      - Other Circulating Biomarkers
    - China Cardiac Biomarkers Market, By Application,
      - Early Detection/Screening
      - Diagnosis
      - Treatment Selection
      - Monitoring
  - India
    - India Cardiac Biomarkers Market, By Circulating Biomarkers
      - Circulating Tumor Cells (CTCs)
      - Circulating Cell-free DNA (cfDNA)
      - Extracellular Vesicles (EVs)
      - Other Circulating Biomarkers
    - India Cardiac Biomarkers Market, By Application,
      - Early Detection/Screening
      - Diagnosis
      - Treatment Selection
      - Monitoring
  - Australia
    - Australia Cardiac Biomarkers Market, By Circulating Biomarkers
      - Circulating Tumor Cells (CTCs)
      - Circulating Cell-free DNA (cfDNA)
      - Extracellular Vesicles (EVs)
      - Other Circulating Biomarkers
    - Australia Cardiac Biomarkers Market, By Application,
      - Early Detection/Screening
      - Diagnosis
      - Treatment Selection
      - Monitoring
  - South Korea
    - South Korea Cardiac Biomarkers Market, By Circulating Biomarkers
      - Circulating Tumor Cells (CTCs)
      - Circulating Cell-free DNA (cfDNA)
      - Extracellular Vesicles (EVs)
      - Other Circulating Biomarkers
    - South Korea Cardiac Biomarkers Market, By Application,
      - Early Detection/Screening
      - Diagnosis
      - Treatment Selection
      - Monitoring
- Latin America
  - Latin America Cardiac Biomarkers Market, By Circulating Biomarkers
    - Circulating Tumor Cells (CTCs)
    - Circulating Cell-free DNA (cfDNA)
    - Extracellular Vesicles (EVs)
    - Other Circulating Biomarkers
  - Latin America Cardiac Biomarkers Market, By Application,
    - Early Detection/Screening
    - Diagnosis
    - Treatment Selection
    - Monitoring
  - Brazil
    - Brazil Cardiac Biomarkers Market, By Circulating Biomarkers
      - Circulating Tumor Cells (CTCs)
      - Circulating Cell-free DNA (cfDNA)
      - Extracellular Vesicles (EVs)
      - Other Circulating Biomarkers
    - Brazil Cardiac Biomarkers Market, By Application,
      - Early Detection/Screening
      - Diagnosis
      - Treatment Selection
      - Monitoring
  - Mexico
    - Mexico Cardiac Biomarkers Market, By Circulating Biomarkers
      - Circulating Tumor Cells (CTCs)
      - Circulating Cell-free DNA (cfDNA)
      - Extracellular Vesicles (EVs)
      - Other Circulating Biomarkers
    - Mexico Cardiac Biomarkers Market, By Application,
      - Early Detection/Screening
      - Diagnosis
      - Treatment Selection
      - Monitoring
  - Argentina
    - Argentina Cardiac Biomarkers Market, By Circulating Biomarkers
      - Circulating Tumor Cells (CTCs)
      - Circulating Cell-free DNA (cfDNA)
      - Extracellular Vesicles (EVs)
      - Other Circulating Biomarkers
    - Argentina Cardiac Biomarkers Market, By Application,
      - Early Detection/Screening
      - Diagnosis
      - Treatment Selection
      - Monitoring
- MEA
  - MEA Cardiac Biomarkers Market, By Circulating Biomarkers
    - Circulating Tumor Cells (CTCs)
    - Circulating Cell-free DNA (cfDNA)
    - Extracellular Vesicles (EVs)
    - Other Circulating Biomarkers
  - MEA Cardiac Biomarkers Market, By Application,
    - Early Detection/Screening
    - Diagnosis
    - Treatment Selection
    - Monitoring
  - South Africa
    - South Africa Cardiac Biomarkers Market, By Circulating Biomarkers
      - Circulating Tumor Cells (CTCs)
      - Circulating Cell-free DNA (cfDNA)
      - Extracellular Vesicles (EVs)
      - Other Circulating Biomarkers
    - South Africa Cardiac Biomarkers Market, By Application,
      - Early Detection/Screening
      - Diagnosis
      - Treatment Selection
      - Monitoring
  - Saudi Arabia
    - Saudi Arabia Cardiac Biomarkers Market, By Circulating Biomarkers
      - Circulating Tumor Cells (CTCs)
      - Circulating Cell-free DNA (cfDNA)
      - Extracellular Vesicles (EVs)
      - Other Circulating Biomarkers
    - Saudi Arabia Cardiac Biomarkers Market, By Application,
      - Early Detection/Screening
      - Diagnosis
      - Treatment Selection
      - Monitoring
  - UAE
    - UAE Cardiac Biomarkers Market, By Circulating Biomarkers
      - Circulating Tumor Cells (CTCs)
      - Circulating Cell-free DNA (cfDNA)
      - Extracellular Vesicles (EVs)
      - Other Circulating Biomarkers
    - UAE Cardiac Biomarkers Market, By Application,
      - Early Detection/Screening
      - Diagnosis
      - Treatment Selection
      - Monitoring

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.